Thus, a deficiency of TGFB3 during early myogenesis could result in hypomyoplasia throughout development that clinically mimics, but is etiologically and histologically distinct from, the myopathy caused by excess TGF-β signaling found in MFS. Here, TGFB3 is linked to myopathy.